| Grace Taylor, LPC | |
|
3358 S 2nd St Ste A-c, Cabot, AR 72023-7873 | |
| (501) 286-6053 | |
| (501) 286-6090 |
| Full Name | Grace Taylor |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 3358 S 2nd St Ste A-c, Cabot, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144700725 | NPI | - | NPPES |
| 228751795 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | A2107001 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Grace Taylor, LPC 2809 Forest Home Rd, Jonesboro, AR 72401-5320 Ph: (866) 972-1268 | Grace Taylor, LPC 3358 S 2nd St Ste A-c, Cabot, AR 72023-7873 Ph: (501) 286-6053 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
The ARTORG Center for Biomedical Engineering Research of the University of Bern is the recipient of a grant from JDRF, the leading global funder for type 1 diabetes research.
Takeda Pharmaceutical Company Limited ("Takeda") today announced that its wholly owned subsidiary, Takeda Global Research & Development Center, Inc. (U.S.), received on September 2 (U.S. TIME), a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for the fixed-dose combination (FDC) of alogliptin and ACTOS(R) (pioglitazone HCl).
Researchers in Milan, Italy, have identified the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the heart tissue of deceased coronavirus disease 2019 (COVID-19) patients who had died from respiratory failure, without showing any signs of cardiac involvement.
Individually tailored anti-clotting medication dosing significantly cut the rate of adverse events after non-emergent percutaneous coronary intervention (PCI) with stenting, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Stent Thrombosis study were presented as a late-breaking clinical trial.
› Verified 3 days ago
Sonya Long, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3358 S 2nd St Ste A-c, Cabot, AR 72023 Phone: 501-286-6053 Fax: 501-286-6090 | |
Chelsea Macy, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 907 S Pine St Ste B, Cabot, AR 72023 Phone: 870-318-5866 | |
Mary Katherine Thompson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3358 S 2nd St Ste A-c, Cabot, AR 72023 Phone: 501-286-6053 | |
Jennifer Poindexter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 405 N 2nd St, Cabot, AR 72023 Phone: 501-733-1408 | |
Mrs. Tammi Renee Ivy, MRC, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3358 Suite D. S. 2nd Street, Cabot, AR 72023 Phone: 501-286-6053 Fax: 870-523-9301 | |
Victoria Kaitlyn Reap, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3358 S 2nd St, Cabot, AR 72023 Phone: 501-286-6053 Fax: 501-286-6090 | |
Mr. Ryan Michael Murphy, M.S. LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 203b Westport Dr, Cabot, AR 72023 Phone: 501-843-9233 Fax: 501-843-9656 |